These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 10431659)

  • 1. Lipoprotein(a): intrigues and insights.
    Hobbs HH; White AL
    Curr Opin Lipidol; 1999 Jun; 10(3):225-36. PubMed ID: 10431659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic rabbits expressing human apolipoprotein(a) as a useful model for the study of lipoprotein(a).
    Fan J; Challah M; Shimoyamada H; Watanabe T
    Ann N Y Acad Sci; 2000 May; 902():347-51. PubMed ID: 10865861
    [No Abstract]   [Full Text] [Related]  

  • 3. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.
    Boffa MB; Marcovina SM; Koschinsky ML
    Clin Biochem; 2004 May; 37(5):333-43. PubMed ID: 15087247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of the gene for apolipoprotein(a) and their association with lipoprotein(a) levels and myocardial infarction.
    Thillet J
    Biochem Soc Trans; 1999 Aug; 27(4):463-6. PubMed ID: 10917621
    [No Abstract]   [Full Text] [Related]  

  • 5. Transgenic rabbits expressing human apolipoprotein (a).
    Fan J; Watanabe T
    J Atheroscler Thromb; 2000; 7(1):8-13. PubMed ID: 11425047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in the ratio between apolipoprotein (a) and lipids in human plasma during interaction with polyclonal sheep antibodies against lipoprotein (a).
    Chernyad'eva IF; Lopata NS; Afanasieva OI; Pokrovskii SN; Kukharchuk VV
    Bull Exp Biol Med; 2002 Apr; 133(4):354-6. PubMed ID: 12124643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a), apolipoprotein(a) phenotypes, and nephropathy in NIDDM patients.
    Akita H; Chiba H; Noritake M; Katsura Y; Udo Y; Shibuya H; Hui SP; Takahashi Y; Nagasaka H
    Diabetes Care; 1996 Sep; 19(9):1036-7. PubMed ID: 8875111
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipoprotein(a): the really bad cholesterol?
    Dieplinger H
    Biochem Soc Trans; 1999 Aug; 27(4):439-47. PubMed ID: 10917617
    [No Abstract]   [Full Text] [Related]  

  • 9. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a).
    Sanan DA; Newland DL; Tao R; Marcovina S; Wang J; Mooser V; Hammer RE; Hobbs HH
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4544-9. PubMed ID: 9539774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential apolipoprotein(a) isoform expression in heterozygosity is an independent contributor to lipoprotein(a) levels variability.
    Noto D; Pace A; Cefalù AB; Barbagallo CM; Rizzo M; Marino G; Emmanuele G; Travali S; Notarbartolo A; Averna M
    Clin Chim Acta; 2003 Feb; 328(1-2):91-7. PubMed ID: 12559603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(A), a unique atherogenic lipoprotein, review on the literature and methodology.
    Pursiainen M
    Oral Surg Oral Diagn; 1993; 4():35-8. PubMed ID: 8935104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a): an emerging cardiovascular risk factor.
    Lippi G; Guidi G
    Crit Rev Clin Lab Sci; 2003 Feb; 40(1):1-42. PubMed ID: 12627747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein(a) as a coronary risk factor in Japanese patients with Type II (non-insulin-dependent) diabetes mellitus. Relation with apolipoprotein(a) phenotypes.
    Murakami K; Ishibashi S; Yoshida Y; Yamada N; Akanuma Y
    Diabetologia; 1998 Nov; 41(11):1397-8. PubMed ID: 9833951
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
    Sechi LA; Zingaro L; Catena C; Perin A; De Marchi S; Bartoli E
    Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and metabolism of lipoprotein (a).
    Marcovina SM; Morrisett JD
    Curr Opin Lipidol; 1995 Jun; 6(3):136-45. PubMed ID: 7648002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of atherogenic remnants and lipoprotein(a) in the nephrotic syndrome: relation to remission of proteinuria.
    Joven J; Simó JM; Vilella E; Camps J; Espinel E; Villabona C
    Clin Chem; 1995 Jun; 41(6 Pt 1):908-13. PubMed ID: 7768011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein(a). Link between structure and pathology.
    Scanu AM
    Ann Epidemiol; 1992 Jul; 2(4):407-12. PubMed ID: 1342291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherogenesis in transgenic mice expressing human apolipoprotein(a).
    Lawn RM; Wade DP; Hammer RE; Chiesa G; Verstuyft JG; Rubin EM
    Nature; 1992 Dec; 360(6405):670-2. PubMed ID: 1465128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients.
    Wanner C; Bartens W; Walz G; Nauck M; Schollmeyer P
    Nephrol Dial Transplant; 1995; 10(1):75-81. PubMed ID: 7724034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoprotein(a) and atherosclerosis.
    Ishibashi S
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):1-2. PubMed ID: 11145926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.